Investors set sail toward China's rapidly growing device market
13 February 2015
Amid rapid growth in China's medical device sector, investors are looking to cash in on the market with a string of M&A deals.
Eyeing $14B epilepsy market, biopharma firm moves to Philly suburb
12 February 2015
The story of Marinus Pharmaceuticals, a biophamraceutical company developing new treatments for epilepsy and other neuropsychiatric disorders. The market for epilepsy treatments is estimated at more than $14 billion. Marinus is initially targeting a $4 billion subset of that market: patients with seizures who don't respond or are no longer responding to other medications in the market.
Game-changer: A new plan takes shape to spur the U.K.'s biotech cluster
12 February 2015
he common wisdom about the U.K.'s life sciences industry has been set in stone for years now. Great drug science is ingrained in the country's stellar academic centers, building on decades of outstanding lab work. But the biotech industry has never achieved the kind of success that the science would seemingly portend, unable to spawn the development of a key cluster like Cambridge/Boston and the sprawling San Francisco Bay Area life sciences hub.
Will Economic Returns from Drugs Continue to Disintegrate?
12 February 2015
Russian medical companies enter Syrian and Indian markets
11 February 2015
Russia may soon start exporting medical products to Syria and India. Russian manufacturers signed a number of agreements at the most recent international Arab Health 2015 exhibition in the UAE, the largest show of medical production innovation in the Middle East and the second largest globally, announced the website of the Russian Ministry of Industry and Commerce.
Russians and Americans develop early-stage cancer diagnostics in Siberia
11 February 2015
Researchers at the Russia-US Anti-Cancer Center in Barnaul, in Southwest Siberia, a joint project launched more than a year ago on the premises of Altay State University, say it will take them three years to complete the testing of a technology which is believed to enable physicians to rapidly diagnose cancers at very early stages, using literally just one drop of a patient’s blood.
Why crowdfunding will never be a big factor in biotech
11 February 2015
Against the backdrop of a surge in venture investing in biotech, there's been a significant amount of curiosity in the startup field about whether crowdfunding can ever play a significant role in seeding new operations.
FDA to pharma: Scrap that fine-print risk info in DTC ads
11 February 2015
Look for some big changes next time you run across a magazine ad for Crestor or Viagra or any of the brands on heavy rotation. The FDA has decided that its long-standing disclose-all policy on side effects was wrong. Way wrong.
How Device Makers Can Take Healthcare "Beyond the Pill"
10 February 2015
In the aftermath of the frenzy of JPMorgan Healthcare Conference that concluded mid January in San Francisco, the life sciences industry is taking stock of the themes emerging for 2015 and beyond.
FDA seeks budget boost for precision medicine IT infrastructure
10 February 2015
The FDA has requested $2 million in President Obama's 2016 budget to build precision medicine-related IT infrastructure. The regulator highlighted cloud computing and data security as areas in which it needs to improve.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024